col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


27 Ergebisse       Seite 1

 [1] 
Springer (Biomed Central Ltd.): Cardiovascular Diabetology
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Feb―20 Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus Inés Valencia, Jairo Lumpuy-Castillo, Giselle Magalhaes, Carlos F. Sánchez-Ferrer, Óscar Lorenzo, Concepción Peiró
2 [GO] 2022―Dez―31 Cardiac adipose tissue volume assessed by computed tomography is a specific and independent predictor of early mortality and critical illness in COVID-19 in type 2-diabetic patients Etienne Charpentier, Alban Redheuil, Olivier Bourron, Samia Boussouar, Olivier Lucidarme, Mohamed Zarai, et al. (+22)
3 [GO] 2022―Dez―15 Patients with type 1 and type 2 diabetes hospitalized with COVID-19 in comparison with influenza: mortality and cardiorenal complications assessed by nationwide Swedish registry data Robin Kristófi, Johan Bodegard, Viveca Ritsinger, Marcus Thuresson, David Nathanson, Thomas Nyström, et al. (+2)
4 [GO] 2022―Okt―19 The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19) Gemma Llauradó, Bogdan Vlacho, Matthieu Wargny, Yue Ruan, Josep Franch-Nadal, Pere Domingo, et al. (+535)
5 [GO] 2022―Sep―21 Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system Arneaux Kruger, Mare Vlok, Simone Turner, Chantelle Venter, Gert Jacobus Laubscher, Douglas B. Kell, Etheresia Pretorius
6 [GO] 2022―Sep―19 Immune-inflammatory biomarkers and the risk of cardiac injury in COVID-19 patients with diabetes: a retrospective cohort study Yi Bo, Cai Yuli, Wang Ye, Li Junfeng, Chen Xiaolin, Bao Yan, Wen Zhongyuan
7 [GO] 2022―Aug―06 Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC) Etheresia Pretorius, Chantelle Venter, Gert Jacobus Laubscher, Maritha J Kotze, Sunday O. Oladejo, Liam R. Watson, et al. (+3)
8 [GO] 2022―Jul―21 Proteomic analysis of cardiometabolic biomarkers and predictive modeling of severe outcomes in patients hospitalized with COVID-19 Philip H. Schroeder, Laura N. Brenner, Varinderpal Kaur, Sara J. Cromer, Katrina Armstrong, Regina C. LaRocque, et al. (+6)
9 [GO] 2022―Feb―14 Real world data on cardiometabolic diseases in U.S. adults during the SARS-CoV-2 pandemic: a decentralized registry study Parth Shah, Kim Magee, Kiara H. Buccellato, McKenna Ismond, Jalisa Watson
10 [GO] 2021―Okt―28 Correction to: Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system Michal Herman-Edelstein, Tali Guetta, Amir Barnea, Maayan Waldman, Naomi Ben-Dor, Yaron D. Barac, et al. (+4)
11 [GO] 2021―Okt―01 The management of type 2 diabetes before, during and after Covid-19 infection: what is the evidence? Leszek Czupryniak, Dror Dicker, Roger Lehmann, Martin Prázný, Guntram Schernthaner
12 [GO] 2021―Sep―04 Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases José Miguel Rivera-Caravaca, Stephanie L. Harrison, Benjamin J. R. Buckley, Elnara Fazio-Eynullayeva, Paula Underhill, Francisco Marín, Gregory Y. H. Lip
13 [GO] 2021―Aug―23 Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin Etheresia Pretorius, Mare Vlok, Chantelle Venter, Johannes A. Bezuidenhout, Gert Jacobus Laubscher, Janami Steenkamp, Douglas B. Kell
14 [GO] 2021―Aug―12 Cardiac adipose tissue volume and IL-6 level at admission are complementary predictors of severity and short-term mortality in COVID-19 diabetic patients Franck Phan, Samia Boussouar, Olivier Lucidarme, Mohamed Zarai, Joe-Elie Salem, Nadjia Kachenoura, et al. (+17)
15 [GO] 2021―Jul―20 Epicardial adipose tissue and severe Coronavirus Disease 19 Hélène Bihan, Richard Heidar, Aude Beloeuvre, Lucie Allard, Elise Ouedraogo, Sopio Tatulashvili, et al. (+4)
16 [GO] 2021―Jul―10 Statins and clinical outcomes in hospitalized COVID-19 patients with and without Diabetes Mellitus: a retrospective cohort study with propensity score matching Prateek Lohia, Shweta Kapur, Sindhuri Benjaram, Zachary Cantor, Navid Mahabadi, Tanveer Mir, M. Safwan Badr
17 [GO] 2021―Mai―07 Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte Nunzia D’Onofrio, Lucia Scisciola, Celestino Sardu, Maria Consiglia Trotta, Marisa De Feo, Ciro Maiello, et al. (+20)
18 [GO] 2021―Apr―27 Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system Michal Herman-Edelstein, Tali Guetta, Amir Barnea, Maayan Waldman, Naomi Ben-Dor, Yaron Barak, et al. (+4)
19 [GO] 2021―Mrz―23 Impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19 pandemic Raúl Moreno, José-Luis Díez, José-Antonio Diarte, Pablo Salinas, José María de la Torre Hernández, Juan F. Andres-Cordón, et al. (+31)
20 [GO] 2020―Dez―18 Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry Giuseppe De Luca, Miha Cercek, Lisette Okkels Jensen, Marija Vavlukis, Lucian Calmac, Tom Johnson, et al. (+54)
21 [GO] 2020―Dez―05 Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study Abdullah M. Alguwaihes, Mohammed E. Al-Sofiani, Maram Megdad, Sakhar S. Albader, Mohammad H. Alsari, Ali Alelayan, et al. (+4)
22 [GO] 2020―Nov―17 Prevalence of readily detected amyloid blood clots in ‘unclotted’ Type 2 Diabetes Mellitus and COVID-19 plasma: a preliminary report Etheresia Pretorius, Chantelle Venter, Gert Jacobus Laubscher, Petrus Johannes Lourens, Janami Steenkamp, Douglas B. Kell
23 [GO] 2020―Okt―01 Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II) Ernesto Maddaloni, Luca D’Onofrio, Francesco Alessandri, Carmen Mignogna, Gaetano Leto, Giuseppe Pascarella, et al. (+10)
24 [GO] 2020―Jul―22 Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies Miriam Longo, Paola Caruso, Maria Ida Maiorino, Giuseppe Bellastella, Dario Giugliano, Katherine Esposito
25 [GO] 2020―Jul―20 Issues for the management of people with diabetes and COVID-19 in ICU Antonio Ceriello, Eberhard Standl, Doina Catrinoiu, Baruch Itzhak, Nebojsa M. Lalic, Dario Rahelic, et al. (+3)
26 [GO] 2020―Jun―11 Impact of diabetes mellitus on clinical outcomes in patients affected by Covid-19 Celestino Sardu, Giuseppe Gargiulo, Giovanni Esposito, Giuseppe Paolisso, Raffaele Marfella
27 [GO] 2020―Mai―11 Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19 Huihui Ren, Yan Yang, Fen Wang, Yongli Yan, Xiaoli Shi, Kun Dong, et al. (+2)
 [1] 

27 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.008 sec